NEW YORK (GenomeWeb News) – French biopharmaceutical firm Hybrigenics said recently that it has acquired the genomics business of biotech company Imaxio for an undisclosed amount.

Hybrigenics said that it received €1.3 million ($1.8 million) through a private placement from Pradeyrol Development to help finance the deal. Pradeyrol is a majority stakeholder in Imaxio.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.